Condition
Chronic Kidney Disease Stage 5 on Dialysis
Total Trials
5
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 4 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 3 (1)
Trial Status
Completed4
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT04282616Not ApplicableCompletedPrimary
An Exercise Facilitator to Activate Simple Training Programs in the Dialysis Center
NCT05270759Completed
Non-invasive Assessment to Predict Tolerance to Fluid Removal on Intermittent Kidney Replacement Therapy
NCT05241652Not ApplicableCompletedPrimary
Inspiratory Muscle Training for Chronic Kidney Disease Patients on Hemodialysis
NCT04743947UnknownPrimary
Vaccination Against COVID-19 in Chronic Kidney Disease
NCT04215120Phase 3CompletedPrimary
Desidustat in the Treatment of Anemia in CKD on Dialysis Patients
Showing all 5 trials